Method for judging feature of malignant tumor

Details Method for judging feature of malignant tumor Method for judging feature of malignant tumor

2007-02-27

2011-10-18

Moran, Marjorie (Department: 1631)

Data processing: measuring, calibrating, or testing

Measurement system in a specific environment

Biological or biochemical

C435S007230

Reexamination Certificate

active

08041514

ABSTRACT:
A method for judging feature of malignant tumor is described. The method comprises obtaining step, first comparing step, second comparing step and judging step. The obtaining step comprises obtaining a first parameter based on activity and expression level of a first cyclin dependent kinase (first CDK) contained in a tumor cell of the malignant tumor, a second parameter based on activity and expression level of a second cyclin dependent kinase (second CDK) contained in the tumor cell, a third parameter based on the first parameter and the second parameter, and a fourth parameter based on expression level of a cyclin contained in the tumor cell. The first comparing step comprises comparing a first threshold value with the third parameter. The second comparing comprises comparing a second threshold value with the fourth parameter. The judging step comprises judging the feature of the malignant tumor based on the comparison results of the first comparing step and the second comparing step.

REFERENCES:
patent: 6193654 (2001-02-01), Richardson et al.
patent: 1 600 513 (2005-11-01), None
patent: 1 686 377 (2006-08-01), None
patent: 1 750 131 (2007-02-01), None
patent: 1 764 615 (2007-03-01), None
patent: WO 2005/020794 (2005-03-01), None
Ishihara et al. (Biochimica et Biophysica Acta, 2005, 1741, 226-233).
Kumar-Sinha et al. (Urology, 2003, 62(Suppl 6b), 19-35).
Dosaka-Akita et al. (Cancer Research, 2001, 61, 2500-2504).
Ross et al. (Proceedings of the American Association for Cancer Research, 1997, 38, 277, #1862).
Kim, J. H., et al, “Amplified CDK2 and cdc2 Activities in Primary Colorectal Carcinoma”, Cancer, American Cancer Society, Philadephia, PA, US, vol. 85, No. 3, Feb. 1, 1999, pp. 546-553, XP002979096.
Kim, S. J., et al, “Prognostic significance of CDKs profiling in breast cancer”, Breast Cancer Research and Treatment, vol. 94, No. Suppl. 1, 2005, pp. S128-S129, XP002438136.
Li, K. K. W., et al, “Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma”, Liver, Copenhagen, DE, vol. 22, 2002, pp. 259-268, XP002979097.
Khandan Keyomarsi, Ph.D., et al., “Cyclin E and Survival in Patients With Breast Cancer”, The New England Journal of Medicine, Nov. 14, 2002, pp. 1566-1575, vol. 347, No. 20, Massachusetts Medical Society, www.nejm.org.
Hisanori Kawamoto, et al., “Short Communication”, American Journal of Pathology, 1997, pp. 15-23, vol. 150, No. 1, American Society for Investigative Pathology.

Affiliated with

Also associated with

Rating

Method for judging feature of malignant tumor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method for judging feature of malignant tumor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for judging feature of malignant tumor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4254406